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Abstract
Background: Client-initiated HIV counselling and testing has been scaled up in many African countries, in the
form of voluntary counselling and testing (VCT). Test rates have remained low, with HIV-related stigma being an
important barrier to HIV testing. This study explored HIV testing decisions in one rural and one urban district in
Zambia with high HIV prevalence and available antiretroviral treatment.
Methods: Data were collected through 17 in-depth interviews and two focus group discussions with individuals
and 10 in-depth interviews with counsellors. Interpretive description methodology was employed to analyse the
data.
Results: ’To know your status’ was found to be a highly charged concept yielding strong barriers against HIV
testing. VCT was perceived as a diagnostic device and a gateway to treatment for the severely ill. Known benefits
of prevention and early treatment were outweighed by a perceived burden of knowing your HIV status related to
stigma and fear. The manner in which the VCT services were organised added to this burden.
Conclusions: This study draws on social stigma theory to enhance the understanding of the continuity of HIV
related stigma in the presence of ART, and argues that the burden of knowing an HIV status and the related
reluctance to get HIV tested can be understood both as a form of label-avoidance and as strong expressions of
the still powerful embodied memories of suffering and death among non-curable AIDS patients over the last
decades. Hope lies in the emerging signs of a reduction in HIV related stigma experienced by those who had been
tested for HIV. Further research into innovative HIV testing service designs that do not add to the burden of
knowing is needed.
Background
“I went there [the VCT centre] and even reached the
door, and immediately I felt weak. I was scared and
left. What if I was told I was positive? I would have
died.”
Woman, not accessed VCT
HIV counselling and testing (HCT) has been pro-
moted as essential in working towards universal access
to prevention, treatment, care and support [1,2].
Although client-initiated HCT has been scaled up in
many African countries, demand is often low, despite
studies demonstrating a high willingness to be tested
[3-5]. The substantial gap between stated willingness to
be tested and actually being tested indicates the pre-
sence of strong acceptability barriers against client-
initiated HCT in its current form. A growing body of lit-
erature concerning HIV testing demonstrates how HIV
test rates are shaped by diverse factors. Educational
attainment appears to facilitate HIV testing [6-8],
whereas risk behaviour presents a more unclear picture
with higher test rates among individuals exhibiting high-
risk behaviour in some areas [8] but lower test rates in
others [9]. Stigma has been demonstrated to be an
important barrier to HIV testing [3,10-13]. It also
appears to influence testing indirectly through barriers
related to confidentiality and privacy concerns [12,14].
Gender-specific barriers among women [5,15] are linked,
* Correspondence: marte.jurgensen@cih.uib.no
1Centre for International Health, University of Bergen, Bergen, Norway
Full list of author information is available at the end of the article
Jürgensen et al. BMC Health Services Research 2012, 12:2
http://www.biomedcentral.com/1472-6963/12/2
© 2012 Jürgensen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
in part, directly or indirectly to stigma. In some areas
where access to antiretroviral treatment (ART) has been
scaled up, reduced stigma and increased test rates have
been demonstrated [16]. However, in other areas the
emergence of new sources of stigma has counteracted
this development [17], and in high-income countries
stigma persists despite almost universal access to treat-
ment [18]. Therefore, HIV-related stigma is located at
the core of attempting to understand the low test rates
in HCT programs.
HIV testing approaches have been much debated. The
traditional approach has been client-initiated HCT, in
the form of voluntary counselling and testing (VCT). A
fundamental premise on which VCT is based is that
everyone has the right to be tested and to know their
HIV status [19]. It follows from this premise that the
right not to know your HIV status is as fundamental as
the right to know. Critics have argued that this rights-
based approach has led to an AIDS exceptionalism,
abandoning regular public health measures in preven-
tion, and that this paradoxically has led to increased vul-
nerability and enhanced stigma [20]. Following these
debates and in an attempt to increase HIV test rates,
UNAIDS and WHO have recommended the implemen-
tation of provider-initiated testing in all health facilities
of countries with generalized HIV epidemics [21]. This
strategy implies that HCT is incorporated into routine
medical care. It is thought that this will diminish the
effects of stigma, as HIV testing will be perceived as an
integral part of the general health assessment. Within a
provider-initiated HCT strategy pre-test counselling is
simplified compared with VCT, and it is commonly
characterized by an opt-out approach, implying that cli-
ents who do not wish to be tested will actively have to
state a lack of willingness to be tested. As provider-
initiated testing has been scaled up, primarily as part of
the prevention of mother to child transmission
(PMTCT) programmes, but also increasingly in general
health services, concerns have been raised concerning
the quality of counselling and particularly the consent
process, as clients may experience limited or no possibi-
lity of opting out and may perceive HIV testing as man-
datory [22-24].
The stigma concept
Stigma has been a component of the HIV/AIDS sce-
nario since the onset of the pandemic, and a large body
of research exists concerning diverse aspects of the phe-
nomenon. The first associations between stigma and
health in social science literature date back to the 1880s,
but the stigma concept was first fully introduced in the
classical sociological works of Goffman, who defined
stigma as “an attribute that is significantly discrediting”
[25]. According to Goffman, the stigmatized person
possesses an “undesirable difference”, and he saw the
conceptualization of what constitutes this ‘difference’ or
‘deviance’ as a social process. Goffman’s idea of stigma
as an attribute has strongly influenced later authors,
leading to highly individualized analyses of stigma, parti-
cularly within social psychology [18]. Although they
have developed substantial knowledge, social psychologi-
cal works have been criticized for having too strong a
focus on the individual and for placing little emphasis
on the social and structural aspects of stigma
[16,18,26-28].
Link and Phelan introduced a more sociologically
oriented approach to understanding stigma, aiming to
link individual and social stigma components and to
emphasize stigma as a constantly changing social pro-
cess [28]. In their conceptualization, stigma exists when
five inter-related components converge; namely ‘label-
ling’, ‘stereotyping’, ‘separation’, ‘status loss and discrimi-
nation’, and the playing-out of ‘social and political
power’. Discrimination can be individual, structural or
self-imposed [18,28]. Parker and Aggleton have added
that stigma and stigmatization occur not merely as a
reaction to differences, but in relation to social and
structural inequalities, and that “stigma plays a key role
in producing and reproducing relations of power and
control” [26]. Castro and Farmer further argue that
structural violence, the large-scale social forces that
shape every society, including social inequalities and
poverty, to a great extent shape stigma and discrimina-
tion and determine who suffers from it [16].
Stigma research has been criticized for neglecting the
lived experience of those affected by it [27,28]. Anthro-
pologists have launched meaning centred approaches,
arguing that the stigma concept remains empty and
decontextualized if not filled with meaning from peo-
ple’s lived experiences [16,29]. They suggest seeing
stigma as a fundamental moral experience, as stigma-
tized conditions threaten what is most at stake for suf-
ferers. Therefore, the process of stigmatization is a
pragmatic response to “perceived threats, real dangers,
and fear of the unknown” [27]. Approaching stigma as a
moral experience allows us to understand those stigma-
tizing and those being stigmatized, as both are involved
in interpreting, living out and reacting to what matters
most and what is threatened. For analytical purposes,
stigma can be divided into enacted stigma and felt
stigma [30]. Enacted stigma can be seen as stigmatizing
attitudes and acts of discriminations by the public,
whereas felt stigma is the stigmatized person’s internal
feelings of shame (self-stigma) and fear of discrimination
(perceived stigma).
Drawing particularly on the writings of Kleinman and
Link and Phelan, this study pursues the central question
of interpreting what is at stake for particular persons in
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a particular context at a particular time. In line with
meaning centred approaches [31], this work argues that
assessing the particularities of the manner in which the
substantial continued reluctance towards testing for HIV
was expressed and where treatment was available is of
substantial value in understanding what is at stake in an
HIV testing context.
HIV prevalence and HIV testing in Zambia
Adult HIV prevalence in Zambia has been estimated at
13.5% [32], and during the last decade important shifts
in the epidemic have been recorded. A decline in HIV
prevalence among young people aged 15 - 24 years has
been documented, probably reflecting a reduction in
incidence in this age group [33,34]. A marked shift in
the association between educational attainment and HIV
infection to reduced risk of HIV infection in more edu-
cated groups, particularly among young people [35], has
been explained by reduced risk behaviour in these
groups [36]. However, in some areas the prevalence has
increased [37], revealing a complex situation with
diverse dynamics.
Client-initiated HCT has been available in Zambia
since the late 1980s in the form of VCT. There was lim-
ited geographical coverage to begin with, but since 1998
there has been a country-wide rollout. In 2007 there
were approximately 700 government- and NGO-run
VCT sites in Zambia (Bristol Cheembo 2007, personal
communication). At the time of this study, provider-
initiated testing was applied in PMTCT-programmes,
but not in the general health service. In 2007, 35% of
women and 20% of men had been tested for HIV and
received the results [38]. This study explored local
meanings related to client-initiated HCT in a rural and
an urban setting in Zambia, with the aim of increasing
knowledge concerning obstacles to HIV testing in set-
tings with a long established high prevalence of HIV
and available antiretroviral treatment. Drawing on social
stigma theory, the aim of this study was to increase
understanding of the continuity of HIV-related stigma
in such settings, and to generate knowledge that could
improve HIV testing strategies.
Methods
The present study was conducted in 2007 in two dis-
tricts of Zambia: Kapiri Mposhi is a predominantly rural
district located in the Central Province with a popula-
tion density of 10.7 per sq km, and Lusaka is an urban
province with a population density of 63.5 per sq km
[39]. In 2005, VCT was available in 58% and antiretro-
viral treatment (ART) in 9% of health care facilities in
the Central Province, whereas in Lusaka VCT was avail-
able in 52% and ART available in 32% of health care
facilities [40]. However, at the time of the study ART
was being scaled up, and the availability of these services
was expected to be higher than in 2005. In Central Pro-
vince 15.0% of men and 16.1% of women had been
tested for HIV and received the result in the year prior
to the survey, whereas in Lusaka Province the corre-
sponding figures were 13.6% and 24.8% [38].
To explore the obstacles to VCT, a qualitative study
design with in-depth interviews and focus group discus-
sions was chosen. The focus group discussions were not
part of the original research protocol but were included
to enrich the data, to validate the findings from the
interviews and to ensure that young people were repre-
sented. We expected that individual interviews would be
most appropriate for the data collection, due to the sen-
sitive nature of HIV testing decisions, and was therefore
surprised by how much the focus group discussions
added to and enriched the material.
In total, 17 in-depth interviews and two focus group
discussions were conducted with individuals (Table 1),
and 10 in-depth interviews were conducted with VCT
counsellors (Table 2). Individuals were recruited on a
voluntary basis, with the assistance of neighbourhood
health committees or health workers. Purposive sam-
pling was employed to ensure the participation of infor-
mants who had accessed VCT and informants who had
not used the service, and to ensure variation in terms of
age and gender. The informants are described in table 1.
We decided to include both men and women in the
same focus groups, because HIV testing experiences
were seen as a cross-cutting issue and because we con-
sidered it to be appropriate and acceptable in this set-
ting, based on previous experience in the same areas.
The active discussions, with both men and women parti-
cipating actively, confirmed this. Counsellors were pur-
posively sampled from various service providers to
include a diversity of experiences. Three counsellors
were recruited from public hospital-based or clinic-
based VCT centres and five from three NGOs providing
VCT, and two were community counsellors. The coun-
sellors interviewed are described in table 2. Recruitment
of further informants (individuals and counsellors) was
ended when we got a sense of saturation through obser-
ving major recurrent patterns with regards to testing in
the data material.
The in-depth interviews were guided by semi-struc-
tured interview guides drafted prior to the study. The
guides were revised and further developed throughout
the interview process, and questions concerning barriers
to HIV testing were added after the emergence of these
topics during earlier interviews. The focus group discus-
sions were guided by a topic guide, covering the same
major topics as the interview guide. As the focus group
discussion was conducted at the end of the data collec-
tion in each study area, it also incorporated information
Jürgensen et al. BMC Health Services Research 2012, 12:2
http://www.biomedcentral.com/1472-6963/12/2
Page 3 of 11
obtained in the individual interviews. The interviews and
focus group discussions were carried out in people’s
homes, outside or at health facilities, depending on con-
venience and the preference of the participants. The
focus groups and the majority of individual interviews
were conducted in the local language by a medical
anthropologist (the second author) or a trained research
assistant with substantial experience from qualitative
work. Some interviews were conducted in English by the
first author, including the interviews with counsellors.
The interviews were recorded, transcribed verbatim and
translated directly by the research assistant. The aim
was to retain transcripts verbatim and translations as
close as possible to the actual stated content. Three
interviews were excluded due to poor sound quality in
the recordings; one counsellor, one individual who had
accessed VCT and one individual who had not accessed
VCT. The early interviews were followed by a thorough
discussion of the content within the research team, as
part of the continuous reflection and analysis. Informal
discussions with health personnel, informants before
and after interviews, and others informed the analysis.
Drawing on interpretive description methodology, the
data were processed and analysed throughout the
research process [41,42]. Conceptual themes were
derived inductively from reading and discussing the
early transcripts, through constant comparison within
and between the interviews, searching for both com-
monalities and differences. The key themes identified in
each interview were further explored systematically and
challenged in succeeding interviews and focus group dis-
cussions, and subsequently in the more rigorous pro-
cesses of analysis by the first author after collection of
the data was completed. As the in-depth interviews and
the focus group discussions covered the same topics, it
was natural to integrate both in the analysis. Hence, the
in-depth interviews and the focus group discussions
were treated equally in the analysis, with comparison
both within and between the transcripts. The major
message of VCT campaigns, “to know your status”,
emerged as an overarching category in the analysis. This
message had diverse meanings to the informants, and
these meanings emerged as themes. To know your sta-
tus was seen as a benefit, such as taking care of your
health, gaining access to treatment and preventing
transmission of HIV. However, to know your status
could also mean to know you would be discriminated
against, fear of moral judgement, fear of loss of future
opportunities, and an experience of getting a death sen-
tence. These meanings are described in the Results
section.
All participants provided oral consent for participation
in the study. No names were recorded, and confidential-
ity was ensured throughout the interviews and focus
Table 1 Overview of informants
Location Person VCT status Sex Age Comment




3 Accessed Male 49
4 Accessed Female 34
5 Not accessed Female 46
6 Not accessed Male 54
7 Not accessed Male 28
8 Not accessed Female Not
transcribed
FGD 1 Not accessed Male 18
2 Not accessed Male 32
3 Not accessed Female 49
4 Not accessed Female 20
5 Not accessed Female 36
6 Not accessed Female 35
7 Not accessed Female 19
8 Not accessed Male 17
9 Not accessed Male 20
Lusaka IDIs 1 Accessed Male 50
2 Accessed Female 32
3 Accessed Male 35
4 Accessed Female 40
5 Accessed Male 42
6 Accessed Male Not
transcribed
7 Not accessed Male 33
8 Not accessed Female 26
9 Not accessed Female 38
FGD 1 Not accessed Male 22
2 Not accessed Female 18
3 Not accessed Female 22
4 Not accessed Male 23
5 Not accessed Female 21
6 Not accessed Female 24
7 Not accessed Male 24
8 Not accessed Female 18
Table 2 Overview of counselors interviewed
Counsellors Service type Sex Comment





Lusaka 1 NGO Male
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group discussions. The study was approved by the
Research Ethics Committee at the University of Zambia.
In both districts, permission was obtained to work with
clinic staff and neighbourhood health committees from
the District Medical Officer and the local health facil-
ities. Permission to interview staff was obtained from
NGOs providing VCT within the study districts.
Results
Perceived benefits of VCT
Two major benefits of VCT were continuously brought
up during the interviews and focus group discussions in
both research settings, namely receiving a diagnosis
related to deteriorating health and receiving access to
treatment. Of the ten informants who had accessed
VCT, eight had done so because they had experienced
health problems and wished to confirm their suspicion
of being HIV-positive. Several of the informants had
been so severely ill that they in reality had not made the
decision to be tested themselves.
“Before I went for VCT, I was very sick most of the
time. Malaria never ended, I was feverish and had
sores in my mouth. That’s when I thought of going
for VCT.”
Woman 36 years, accessed VCT, IDI
For these informants, VCT was employed as a diagnos-
tic device after they had fallen ill. Although the infor-
mants who had accessed VCT had knowledge of the
potential preventive benefits of VCT and emphasized the
importance of being tested while one was healthy, only
two of the informants were healthy when they accessed
VCT. One of these was tested because she considered
herself to be at risk owing to her work as a traditional
birth attendant, whereas the second was the only infor-
mant to be tested simply to know his HIV status. The fol-
lowing quotations from one of the informants are
illustrative of the apparent contrast between knowing the
importance of testing and actual behaviour. When asked
when people should generally go for VCT he replied:
“Any time, whenever they feel they have to know
their status...one should go for it.”
However, when asked about why he had thought of
going for VCT himself he said:
“I started suspecting that there might be something
wrong with me. My weight started decreasing, then I
got a lot of diseases that I had never had before. So
with me I can say I was lucky because that made me
go for it [VCT].”
Man, 50 years, accessed VCT, IDI
Similar reasoning became evident in response to the
question of whether one should be tested if treatment
was not available. While several informants who had
been tested argued for the importance of knowing one’s
status even if treatment was not available, most infor-
mants said that they would not have been tested if there
was no treatment. The counsellors confirmed that the
majority of their clients came for VCT because of illness
and with the aim of starting treatment.
Respondent: Most of the people who decide to come
for VCT; it’s because of the ART clinic.
Interviewer: So if there was no medicine...?
Respondent: It wouldn’t happen. People would not
come for VCT.
Man 33 years, not accessed VCT, volunteer at
ART clinic, IDI
The apparent ambiguity of knowing the benefits of
testing, combined with a reluctance to get tested while
still healthy, was evident among informants who had
not accessed VCT. Most of these informants eagerly
emphasized the health benefits of counselling and of
being tested for HIV while still being well and healthy.
Some of the informants also stated they were motivated
to be tested, highlighting these benefits. Simultaneously,
they expressed that for themselves they would not seek
VCT before they fell ill and needed treatment. The fol-
lowing brief dialogue provides an illustration of the
apparent ambivalence present in the informants’
accounts:
I: So why are you saying VCT is a good thing?
R: Because I have seen it has helped a lot of people.
Those found to be positive, now they are being
given the ARVs. So I think it’s good. (...) I think for
someone who is negative, it is good because such a
person will continue protecting his or her life. (...)
I will go there one day but not now.
I: Not now?
R: Not now, because I am not ready.
I: What is making you not to be ready?
R: Mmm...I am scared.
I: You are scared of what?
R: Of finding myself to be positive. I don’t know
how I will live. I am scared to be told that I am
HIV-positive. I think I will die. (...) Now what I
think is when I get sick I will go for VCT.
I: So you can only go for VCT when you are sick?
R: That’s what I think.
Woman, 26 years, not accessed VCT, IDI
One of the informants interviewed worked as a volun-
teer at the local ART clinic. When asked about when he
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would go for testing he said:
R: One day I will think of doing so.
I: When...?
R: When I am ready. (...) You see, if a person is
healthy, and he is not feeling anything, there is no
need for going for VCT.
I: Do you think so?
R: (laughs) This is what I think.
I: But I asked you a question earlier about when one
should go for VCT and you said ‘anytime’.
R: Yeah, it depends, but you see most of the people
go for VCT when they are sick.
Man, volunteer at ART clinic, 33 years, not
accessed VCT, IDI
Even VCT counsellors did not always appreciate the
preventive benefit of accessing VCT while feeling
healthy:
“Actually, we do talk to them about prevention,
but . . . actually, what I am trying to say is that
we do talk to them about prevention. But if a cli-
ent comes here, the client needs to have
treatment.”
Counsellor, NGO, IDI
Barriers to VCT - The burden of knowing
HIV testing decisions were characterized by a disturbed
assessment of benefits and barriers, and although infor-
mants were aware of the preventive and treatment bene-
fits implied in testing, strong barriers held them back
from being tested. It emerged from the interviews and
focus group discussions that ‘knowing your status’ was
experienced as a highly charged concept filled with
meaning from the informants’ long term experiences
with HIV/AIDS. Deep fears regarding HIV testing were
revealed, which emerged in surprisingly similar ways in
both research settings, and across age groups and
gender.
When asked why they would not go for VCT, infor-
mants reported a general fear of knowing their status,
although they knew that people could live for long peri-
ods with treatment. Several suspected that they could be
HIV-positive because of previous risk behaviour, but the
diagnosis frightened them so much that they would
rather not know. Informants held that the worry in itself
would accelerate the disease and that they would die
faster if they knew they were HIV-positive, as revealed
below:
“I don’t know if I am positive or negative. It’s better
I am just like this because I look fit. But when I
know my status I will have mental torture, I will get
thin. And I will only live a few years and die early.
Then what have you done on earth? Nothing.”
Man 24 years, not accessed VCT, FGD
“Now what I think is when I get sick I will go for
VCT. Because if I go for VCT now and the result is
[HIV] positive, then I will get sick because I will be
thinking a lot.”
Woman 26 years, not accessed VCT, IDI
For many informants the prospect of intense thinking
and worrying was perceived as being so detrimental to
their health that they would rather not know. Although
treatment was available in both study areas, those who
had not been tested still talked about HIV as a death
sentence, as was confirmed by the counsellors:
“What is it that they fear? Just HIV in itself.
Because they think that once you are HIV posi-
tive, the next thing is death.”
Counsellor, NGO, IDI
In the rural study area, several informants told anec-
dotes about people who had committed suicide after
testing positive for HIV in order to avoid the immense
social and physical suffering they had seen among those
dying from AIDS.
“There are people who commit suicide immediately
after they have been told that he or she is HIV posi-
tive. In this area there have been five people. Young
men, mostly. One of them threw himself in a pit
and died.”
Woman 34 years, accessed VCT, IDI
HIV-positive people were often labelled as ‘moving
corpses’. Another common label was the Nyanja term
‘kanayaka’: literally translated as ‘it has ignited’ or ‘the
fire has started’. This expression is commonly used for
contagious diseases, but the interpretation has gained
additional dimensions in an AIDS context with the
interpretation being that one’s life had come to an end,
and that the inevitable course against death could not
be prevented. In addition, the notion of fire pointed to a
warning light, making a person’s risk behaviour and
HIV status visible, and signalling that death had come
or one was already dead. It also indicated that the per-
son posed a danger to the community, and igniting the
fire was thus a metaphor for the suspected spread of the
disease to other people, like the spread of fire.
“They laugh at you if you go for VCT. It means that
you have that suspicion of being HIV positive. They
place you as already positive if you go for VCT.
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They say: Look at that one, she is even going for
VCT, maybe kanayaka!”
Woman 32 years, accessed VCT, IDI
“So this is the reason why some of us...we fear to go
for VCT. People will say kanayaka, he will die soon.”
Man 33 years, not accessed VCT, IDI
As the most common motivations for HIV testing were
accelerated deterioration of one’s health or a perceived risk,
it was common to assume that those presenting for testing
were already suffering from AIDS and that they had ‘misbe-
haved’ sexually. Although many informants, particularly
counsellors, would state that the HIV related stigma was
less evident than in the past, HIV was still, after several dec-
ades, strongly associated with promiscuity and prostitution,
particularly among those who had not been tested. Most of
the informants linked an HIV diagnosis, or just being seen
at the VCT site, with substantial loss of moral standing and
discrimination from families and communities.
“The fear that I know, it’s the way people are going
to look at you. Maybe everyone in the community
they know me as a person. They respect me today,
but the moment they hear I am HIV positive, they
conclude: ‘so she has been sleeping around. She was
just pretending to be a good person at home or in
the community’.”
Woman 24 years, not accessed VCT, FGD
Young informants expressed strong barriers to VCT.
They articulated concerns about the loss of future
opportunities for education, work and marriage if they
were tested and found positive, both due to the loss of
moral standing and due to the assumption that they
would die soon. Several informants stated that just
being seen at the VCT centre could mean the end of
such future opportunities.
“Another reason why people don’t want to go for
VCT is, for example, at my workplace they don’t
want people with AIDS. If I they found out that I
have the virus, it means that I will stop working
there and then . . . so for me, even if I get sick I
can’t go for VCT. So that I lose my work? No.”
Woman 22 years, not accessed VCT, FGD
“Like me, I am a student. So I wouldn’t feel good if I
was found to be HIV positive, because I would think
why should I get educated? Very soon I am dying.
It’s even better to stop [education].”
Woman 18 years, not accessed VCT, FGD
The fear of being seen as a living corpse, as a person
on fire, and as a person with immoral conduct naturally
had implications for perceptions of VCT centres.
“On the other side [of the clinic] people with malaria
or other diseases wait, and when you come for VCT
you must pass them. And when they see you, people
say ‘obviously that one misbehaved, why else is she
going there?”
Woman 24 years, not accessed VCT, FGD
The fact that in many cases the arrangement of the
VCT facilities compromised confidentiality and contrib-
uted to the ‘burden of knowing’ was a striking finding.
Usually VCT was located in a separate building or a
particular room of the clinic, making it clearly visible to
people. Informants feared being seen at the VCT centre
or in the queue for VCT, as people would assume them
to be HIV-positive and to have ‘misbehaved’.
“Immediately, the moment they know that you have
been for VCT, that’s it. They start pointing at you
saying that you have got AIDS. So that’s why some
fear to go for VCT, because everyone would think
you have AIDS, even if you don’t have. Just because
you went for VCT you have AIDS. [...] Even when
you just go to the hospital, they may say you have
AIDS.”
Man 54 years, not accessed VCT, IDI
“They will say we saw you or we saw him at the
VCT centre. For example if you want to propose
someone for marriage, it won’t work if you’ve been
seen at the VCT centre.”
Man 32 years, not accessed VCT, FGD
Informants were worried about being seen at or leaving
the VCT centre after testing and about how they would
manage to keep a straight face in front of all the people
at the clinic. In some clinics, HIV-positive patients still
received a clinic card or envelope of a particular colour,
different from the other clinic cards, making it readily
visible to others who were the HIV patients.
“It’s too open. You are just seated there [the clinic],
and whoever you see with a khaki coloured envel-
ope, you conclude they are on ARVs”.
Woman 36 years, not accessed VCT, FGD
Some informants who had accessed VCT confirmed
the concerns of stigma and discrimination. However, the
picture was not unequivocal. A few of the informants
who were HIV positive had not experienced discrimina-
tion in their communities, and held that their openness
and improvement on treatment had encouraged others
to go for testing.
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“In the community there is actually no discrimina-
tion against me. I have even encouraged some peo-
ple to go for VCT, and they have accepted the
advice that I have given them.”
Man 35 years, HIV positive, accessed VCT, IDI
Discussion
The findings of this study demonstrate that VCT was
not employed as a preventive measure, as stated as one
of the aims of the service, but rather as a diagnostic tool
after a person had fallen ill. To the majority of infor-
mants, the concept ‘to know your status’ meant con-
firming an expected diagnosis and gaining access to
ART. Therefore, VCT was perceived as a diagnostic
device and a gateway to treatment. The preventive mes-
sages concerning gaining knowledge about an HIV nega-
tive status and how to remain negative, or alternatively
gaining knowledge about an HIV positive status and
early access to treatment, were not perceived as power-
ful enough benefits to motivate people to go for testing.
The fear of knowing ones HIV status originated from
perceiving an HIV-positive result as a death sentence
and from the anticipation of severe stigma. To the study
participants, ‘to know your status’ meant to know that
they existed somewhere between life and death or were
already dead. ‘To know your status’ implied knowing
that the fire had ignited and that life would inevitably
soon burn out. Furthermore, an HIV positive status
implied loss of moral standing, loss of support and loss
of future opportunities. It meant living with a warning
light flashing for everyone to see and talk about. In this
manner ‘to know your status’ conjured up meanings so
strong that the burden of knowing outweighed the bene-
fits of prevention, as well as of early treatment.
Briefly drawing on the writings of Link and Phelan
[28] concerning stigma processes may shed light on the
complex processes at work. As described in the back-
ground section, the authors suggest five inter-related
components of stigma, namely: (i) people distinguish
and label human differences (labelling); (ii) dominant
cultural beliefs link labelled persons to undesirable char-
acteristics (stereotyping); (iii) labelled persons are placed
in distinct categories separating ‘us’ from ‘them’ (separa-
tion); (iv) labelled persons experience loss of position
and are commonly discriminated against in ways that
lead to unequal outcomes (status loss and discrimina-
tion); (v) stigmatization is contingent on access to ways
of playing out social, economic and political power. In
the current study, people were labelled and pointed out
as HIV positive, sometimes just by being seen at the
testing site. Stereotyping surfaced by linking an HIV
positive status to the ‘immoral’ characteristics of promis-
cuity and prostitution, and even more strongly through
the concepts of ‘moving corpses’, ‘living dead’ and ‘fire
being ignited’, suggesting that HIV is seen as an unna-
tural state threatening the usual categories of life and
death [43]. These labels and stereotypes were employed
to mark a distance between ‘us’ and ‘them’ actively. In
order to distinguish between right and wrong people
will everywhere mark a separation between moral and
immoral realms or communities, and people may go to
great lengths to ensure that they remain within the right
category. A separation is thus created between moral
and immoral conduct, and in our study HIV positive
people were located in an immoral category that was
separate from the normal moral community. Being
located in the immoral category may have devastating
implications for one’s reputation and in terms of loss of
status, leading to discrimination and marginalisation.
For example, the perceptions of HIV positive people as
‘dead’ or ‘living dead’ had implications for future invest-
ment in people in terms of education, jobs and mar-
riage. Not only did an HIV positive status imply a threat
to an individual’s future opportunities, but it also
implied a threat to the people around him or her. The
metaphor of igniting a fire powerfully reveals the per-
ceptions of the risk that HIV positive people are per-
ceived to pose to the community, making it justifiable
and possibly even important to label, stereotype and
separate the infected from the non-infected. Discrimina-
tion also works to frighten others from gaining an HIV
positive status. These findings demonstrate that gaining
an HIV positive diagnosis was related to anticipation of
stereotyping, status loss and discrimination, or a ‘discre-
dited status’ to use Goffman’s terms [25], to a point
where the burden of knowing was perceived as too
heavy to relate to. The process of stigmatization of HIV
positive individuals implies the playing out of power
gained from the sense of being part of a moral commu-
nity, being clean, healthy and alive vs. a community of
immoral, dead or dying individuals that one should fear.
This power dimension has been noted by diverse scho-
lars of HIV [16,26], but has not been explored in depth
in the present study.
Drawing on stigma research from other fields within
health may be useful when attempting to understand
how HIV-related stigma influences HIV testing seeking
behaviour. The modified labelling theory has been sug-
gested to explain how labels may lead to negative out-
comes in individuals [44]. People may be labelled as
HIV-positive in different ways. Labels may be obtained
from others, such as receiving a diagnosis from a doctor
or a counsellor, or they can be acquired by association
[45], such as being observed at the HIV testing room or
centre. Public labelling by association, such as being
seen at the VCT centre or room, was common in the
two research settings. The fear of enacted stigma after
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being labelled by association is prominent among our
informants, and their decision to avoid testing as long
as possible can therefore be seen as a form of label-
avoidance. By avoiding the test rooms and clinics, they
avoid being labelled by the community and thereby
avoid the anticipated public stigma and its harm. In our
material we also see how self-stigma is prominent. In an
area with a longstanding epidemic and widespread
stigma, people will tend to internalize the stigmatizing
attitudes that they have experienced as common in the
community. People at risk of being HIV infected will
therefore think that they are less worth if they are found
to be HIV positive. This may lead to low self-esteem
and low self-efficacy [28,45], i.e. what we call self-stigma.
The poor self-efficacy is particularly evident among the
young informants in our study, who believed they would
lose future opportunities if found HIV-positive. In our
material we can understand the intense fear and worry-
ing as a strong expression of self-stigma. Many of the
informants actually believed they would die of worry if
they were to be labelled as HIV-positive, which naturally
held them back from being tested for HIV. This can
thus also be seen as a form of label avoidance. By not
knowing their ‘label’, and not seeking to know it, they
could avoid the fear, shame, devaluation of themselves
and the low expectations to future opportunities.
Yang et al. talk of stigma as a moral experience, seeing
stigmatized conditions as threatening what is most at
stake [27]. Also in the context of ART availability, an
HIV positive diagnosis continues to threaten what is
most at stake for people: moral standing, prospects of a
spouse and family, access to education and work, good
health and survival. Such devastating threats to what is
at stake in local moral worlds have created a fear so
strong that an HIV positive diagnosis was assumed by
our informants to lead to worries causing accelerated
disease and an early death, as has also been found in
studies carried out in other African settings [12,46,47].
A population survey in Zambia demonstrated that a
substantial part of the mental distress related to HIV
was mediated through self-perceived risk and worry of
being HIV infected [48].
It has been anticipated that long experience of HIV in
high prevalence settings and increasing availability of
ART would cause stigma to gradually lose its power. In
some settings such a decrease in stigma has been
reported [16]. However, as is the case in other studies
[17,49], this work reveals that stigma is still powerful
and has a substantial impact on people’s testing beha-
viour. Such continuity of HIV related stigma can only
be understood if one attempts to grasp the implications
of almost three decades of experience with HIV/AIDS
implying early death and dying among the most produc-
tive and reproductive groups, reinforced by the long-
standing message that this disease cannot be cured [43].
The memories of AIDS are embedded in narratives and
experiences of death of people who under normal cir-
cumstances should not die, and have been powerfully
imprinted in people’s minds and bodies. These embo-
died memories [50] of an incurable disease associated
with dehumanizing symptoms will affect future existen-
tial decisions including whether or not to be tested for
HIV. As HIV comes with so much ‘extraordinary bag-
gage’ the transition to a manageable chronic disease will
be difficult and take time [46]. This study argues that
the burden of knowing an HIV status and the related
reluctance to get HIV tested are strong expressions of
the still powerful embodied memories of the suffering
experienced among non-curable AIDS patients.
This study indicates that the way in which VCT ser-
vices were organised substantively added to the burden
of knowing one’s HIV status. The informants revealed
that being exposed at VCT sites was in part due to the
infrastructure and organisational arrangements that did
not ensure patient privacy. Such views have been docu-
mented also in other settings [12,14]. This can be con-
ceptualized as a form of structural or institutional
stigma [18]. Ways of organising the services so that they
do not add to or reinforce the stigma constraining peo-
ple’s testing decisions have been proposed, and studies
in Zambia and other African countries have demon-
strated that when VCT services have been made more
convenient, confidential and locally acceptable through
home-based or mobile services, uptake has increased
substantially [12,51-57]. These studies indicate that the
HIV related stigma may not remain an insurmountable
barrier to HIV testing, and add importantly to debates
concerning HIV testing approaches. In a context where
the implementation of opt-out testing approaches has
been criticized for compromising preventive counselling
and processes of consent [22-24], the above studies pro-
vide hope that opt-in approaches with high standards of
consent and counselling may yield high test rates if one
avoids public exposure experienced at public testing
sites.
The HIV epidemic is characterized by a shifting land-
scape of stigma, and the increasing availability of ART is
hoped and expected to make an impact in the long run.
There is a possibility that the scenario may have chan-
ged since these data were collected in 2007. Some of the
informants had not experienced the anticipated stigma
after being diagnosed with HIV, which may be an indi-
cation of processes of change. In the present study there
was a relatively low representation of young people. As
the motivation to test may be somewhat different
among young people [56], certain dimensions of peo-
ple’s testing decisions may lack in the analysis, and
further research is required in this area. However, young
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people did express the most negative views on receiving
an HIV diagnosis, and we therefore do not think that
including more young people would have given a sub-
stantially different picture of what is presented here. In
our study we only employed one focus group discussion
at the end of the field work in each area. Prior to the
study we anticipated that HIV testing decisions and
experiences would be sensitive issues, and therefore that
the privacy offered in individual in-depth interviews
would be more conducive. Contrary to our expectations,
the interaction in the focus group discussions yielded a
very rich material. If we were to do the study again,
more focus group discussions would have been included
in the study design.
Conclusions
The present study revealed how decisions of whether or
not to be tested for HIV are embedded in social and
interpersonal processes constraining people’s choices.
The strongly promoted message ‘to know your status’
proved to be a highly charged concept yielding strong
barriers against HIV testing. The study revealed that
VCT was perceived as a diagnostic device and a gateway
to treatment for the severely ill. Known benefits con-
cerning prevention and early treatment were outweighed
by a perceived burden of knowing one’s HIV status. The
manner in which VCT services were organised was
found to strongly add to this burden. The burden of
knowing and the related reluctance to get HIV tested
can be understood both as a form of label-avoidance
and as strong expressions of the still powerful embodied
memories of suffering and death among non-curable
AIDS patients over the last decades The meanings con-
structed around HIV testing in the present study are
not entirely new. However, the findings are nonetheless
of importance as meaning always emerges in slightly dif-
ferent forms, and will differ somewhat in content
between people, time and places. Documenting such dif-
ferences through locally grounded knowledge provides
insights into the complexities of why client-initiated
HIV test rates remain low, and may improve our think-
ing about ways ahead in the field of HIV testing. Hope
lies in the emerging signs of a reduction in HIV related
stigma experienced by those who had been tested and
where ART is presently available. Taking seriously how
meaning surfaces in particular times and places remains
vital when we seek to increase our chances of finding
“the difference that makes the difference” [58] in diverse
HIV testing contexts.
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